|
Many Patients With Asthma Do Not Respond to Standard Therapy
Medscape January 6, 2012 — Approximately one half of patients with mild-to-moderate asthma are unlikely to respond to currently available anti-inflammatory therapy because they have persistently noneosinophilic disease, according to the results of a … Study Offers Clues to Why Some Don't Benefit From Asthma Drugs A large subgroup of mild-to-moderate asthma is persistently non-eosinophilic |
View full post on asthma – Google News